ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Modified Pseudouridine Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-16R18111
Home | Market Reports | Science| Biological Sciences
Global RNA Modified Pseudouridine Market Research Report 2024
BUY CHAPTERS

Global RNA Modified Pseudouridine Market Research Report 2025

Code: QYRE-Auto-16R18111
Report
2025-12-23
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
YAMASA Corporation
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
Boc Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

RNA Modified Pseudouridine Market

The global market for RNA Modified Pseudouridine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.
North American market for RNA Modified Pseudouridine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for RNA Modified Pseudouridine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for RNA Modified Pseudouridine in mRNA Vaccines is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of RNA Modified Pseudouridine include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Modified Pseudouridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Modified Pseudouridine.
The RNA Modified Pseudouridine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Modified Pseudouridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Modified Pseudouridine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of RNA Modified Pseudouridine Market Report

Report Metric Details
Report Name RNA Modified Pseudouridine Market
Segment by Type
  • Solution
  • Powder
Segment by Application
  • mRNA Vaccines
  • Gene Expression and Therapy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, Biori
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of RNA Modified Pseudouridine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Modified Pseudouridine Market report?

Ans: The main players in the RNA Modified Pseudouridine Market are YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, Biori

What are the Application segmentation covered in the RNA Modified Pseudouridine Market report?

Ans: The Applications covered in the RNA Modified Pseudouridine Market report are mRNA Vaccines, Gene Expression and Therapy, Other

What are the Type segmentation covered in the RNA Modified Pseudouridine Market report?

Ans: The Types covered in the RNA Modified Pseudouridine Market report are Solution, Powder

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Modified Pseudouridine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solution
1.2.3 Powder
1.3 Market by Application
1.3.1 Global RNA Modified Pseudouridine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 mRNA Vaccines
1.3.3 Gene Expression and Therapy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Modified Pseudouridine Market Perspective (2020-2031)
2.2 Global RNA Modified Pseudouridine Growth Trends by Region
2.2.1 Global RNA Modified Pseudouridine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Modified Pseudouridine Historic Market Size by Region (2020-2025)
2.2.3 RNA Modified Pseudouridine Forecasted Market Size by Region (2026-2031)
2.3 RNA Modified Pseudouridine Market Dynamics
2.3.1 RNA Modified Pseudouridine Industry Trends
2.3.2 RNA Modified Pseudouridine Market Drivers
2.3.3 RNA Modified Pseudouridine Market Challenges
2.3.4 RNA Modified Pseudouridine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Modified Pseudouridine Players by Revenue
3.1.1 Global Top RNA Modified Pseudouridine Players by Revenue (2020-2025)
3.1.2 Global RNA Modified Pseudouridine Revenue Market Share by Players (2020-2025)
3.2 Global RNA Modified Pseudouridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Modified Pseudouridine Revenue
3.4 Global RNA Modified Pseudouridine Market Concentration Ratio
3.4.1 Global RNA Modified Pseudouridine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Modified Pseudouridine Revenue in 2024
3.5 Global Key Players of RNA Modified Pseudouridine Head office and Area Served
3.6 Global Key Players of RNA Modified Pseudouridine, Product and Application
3.7 Global Key Players of RNA Modified Pseudouridine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Modified Pseudouridine Breakdown Data by Type
4.1 Global RNA Modified Pseudouridine Historic Market Size by Type (2020-2025)
4.2 Global RNA Modified Pseudouridine Forecasted Market Size by Type (2026-2031)
5 RNA Modified Pseudouridine Breakdown Data by Application
5.1 Global RNA Modified Pseudouridine Historic Market Size by Application (2020-2025)
5.2 Global RNA Modified Pseudouridine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Modified Pseudouridine Market Size (2020-2031)
6.2 North America RNA Modified Pseudouridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Modified Pseudouridine Market Size by Country (2020-2025)
6.4 North America RNA Modified Pseudouridine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Modified Pseudouridine Market Size (2020-2031)
7.2 Europe RNA Modified Pseudouridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Modified Pseudouridine Market Size by Country (2020-2025)
7.4 Europe RNA Modified Pseudouridine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Modified Pseudouridine Market Size (2020-2031)
8.2 Asia-Pacific RNA Modified Pseudouridine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Modified Pseudouridine Market Size (2020-2031)
9.2 Latin America RNA Modified Pseudouridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Modified Pseudouridine Market Size by Country (2020-2025)
9.4 Latin America RNA Modified Pseudouridine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Modified Pseudouridine Market Size (2020-2031)
10.2 Middle East & Africa RNA Modified Pseudouridine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 YAMASA CORPORATION
11.1.1 YAMASA CORPORATION Company Details
11.1.2 YAMASA CORPORATION Business Overview
11.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Introduction
11.1.4 YAMASA CORPORATION Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.1.5 YAMASA CORPORATION Recent Development
11.2 Biosynth Carbosynth
11.2.1 Biosynth Carbosynth Company Details
11.2.2 Biosynth Carbosynth Business Overview
11.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Introduction
11.2.4 Biosynth Carbosynth Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.2.5 Biosynth Carbosynth Recent Development
11.3 TriLink BioTechnologies
11.3.1 TriLink BioTechnologies Company Details
11.3.2 TriLink BioTechnologies Business Overview
11.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Introduction
11.3.4 TriLink BioTechnologies Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.3.5 TriLink BioTechnologies Recent Development
11.4 MP Biomedicals, Inc
11.4.1 MP Biomedicals, Inc Company Details
11.4.2 MP Biomedicals, Inc Business Overview
11.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Introduction
11.4.4 MP Biomedicals, Inc Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.4.5 MP Biomedicals, Inc Recent Development
11.5 Thermo Scientific Chemicals
11.5.1 Thermo Scientific Chemicals Company Details
11.5.2 Thermo Scientific Chemicals Business Overview
11.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Introduction
11.5.4 Thermo Scientific Chemicals Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.5.5 Thermo Scientific Chemicals Recent Development
11.6 BOC Sciences
11.6.1 BOC Sciences Company Details
11.6.2 BOC Sciences Business Overview
11.6.3 BOC Sciences RNA Modified Pseudouridine Introduction
11.6.4 BOC Sciences Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.6.5 BOC Sciences Recent Development
11.7 Toronto Research Chemical
11.7.1 Toronto Research Chemical Company Details
11.7.2 Toronto Research Chemical Business Overview
11.7.3 Toronto Research Chemical RNA Modified Pseudouridine Introduction
11.7.4 Toronto Research Chemical Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.7.5 Toronto Research Chemical Recent Development
11.8 Wuhan Glycogene
11.8.1 Wuhan Glycogene Company Details
11.8.2 Wuhan Glycogene Business Overview
11.8.3 Wuhan Glycogene RNA Modified Pseudouridine Introduction
11.8.4 Wuhan Glycogene Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.8.5 Wuhan Glycogene Recent Development
11.9 Fine Biotech
11.9.1 Fine Biotech Company Details
11.9.2 Fine Biotech Business Overview
11.9.3 Fine Biotech RNA Modified Pseudouridine Introduction
11.9.4 Fine Biotech Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.9.5 Fine Biotech Recent Development
11.10 Shanghai Hongene Biotech
11.10.1 Shanghai Hongene Biotech Company Details
11.10.2 Shanghai Hongene Biotech Business Overview
11.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Introduction
11.10.4 Shanghai Hongene Biotech Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.10.5 Shanghai Hongene Biotech Recent Development
11.11 Biori
11.11.1 Biori Company Details
11.11.2 Biori Business Overview
11.11.3 Biori RNA Modified Pseudouridine Introduction
11.11.4 Biori Revenue in RNA Modified Pseudouridine Business (2020-2025)
11.11.5 Biori Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
YAMASA Corporation
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
Boc Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori
List of Tables
 Table 1. Global RNA Modified Pseudouridine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Solution
 Table 3. Key Players of Powder
 Table 4. Global RNA Modified Pseudouridine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global RNA Modified Pseudouridine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global RNA Modified Pseudouridine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global RNA Modified Pseudouridine Market Share by Region (2020-2025)
 Table 8. Global RNA Modified Pseudouridine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global RNA Modified Pseudouridine Market Share by Region (2026-2031)
 Table 10. RNA Modified Pseudouridine Market Trends
 Table 11. RNA Modified Pseudouridine Market Drivers
 Table 12. RNA Modified Pseudouridine Market Challenges
 Table 13. RNA Modified Pseudouridine Market Restraints
 Table 14. Global RNA Modified Pseudouridine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global RNA Modified Pseudouridine Market Share by Players (2020-2025)
 Table 16. Global Top RNA Modified Pseudouridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Modified Pseudouridine as of 2024)
 Table 17. Ranking of Global Top RNA Modified Pseudouridine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by RNA Modified Pseudouridine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of RNA Modified Pseudouridine, Headquarters and Area Served
 Table 20. Global Key Players of RNA Modified Pseudouridine, Product and Application
 Table 21. Global Key Players of RNA Modified Pseudouridine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global RNA Modified Pseudouridine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global RNA Modified Pseudouridine Revenue Market Share by Type (2020-2025)
 Table 25. Global RNA Modified Pseudouridine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global RNA Modified Pseudouridine Revenue Market Share by Type (2026-2031)
 Table 27. Global RNA Modified Pseudouridine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global RNA Modified Pseudouridine Revenue Market Share by Application (2020-2025)
 Table 29. Global RNA Modified Pseudouridine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global RNA Modified Pseudouridine Revenue Market Share by Application (2026-2031)
 Table 31. North America RNA Modified Pseudouridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America RNA Modified Pseudouridine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America RNA Modified Pseudouridine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe RNA Modified Pseudouridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe RNA Modified Pseudouridine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe RNA Modified Pseudouridine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific RNA Modified Pseudouridine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific RNA Modified Pseudouridine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America RNA Modified Pseudouridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America RNA Modified Pseudouridine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America RNA Modified Pseudouridine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa RNA Modified Pseudouridine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa RNA Modified Pseudouridine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. YAMASA CORPORATION Company Details
 Table 47. YAMASA CORPORATION Business Overview
 Table 48. YAMASA CORPORATION RNA Modified Pseudouridine Product
 Table 49. YAMASA CORPORATION Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 50. YAMASA CORPORATION Recent Development
 Table 51. Biosynth Carbosynth Company Details
 Table 52. Biosynth Carbosynth Business Overview
 Table 53. Biosynth Carbosynth RNA Modified Pseudouridine Product
 Table 54. Biosynth Carbosynth Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 55. Biosynth Carbosynth Recent Development
 Table 56. TriLink BioTechnologies Company Details
 Table 57. TriLink BioTechnologies Business Overview
 Table 58. TriLink BioTechnologies RNA Modified Pseudouridine Product
 Table 59. TriLink BioTechnologies Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 60. TriLink BioTechnologies Recent Development
 Table 61. MP Biomedicals, Inc Company Details
 Table 62. MP Biomedicals, Inc Business Overview
 Table 63. MP Biomedicals, Inc RNA Modified Pseudouridine Product
 Table 64. MP Biomedicals, Inc Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 65. MP Biomedicals, Inc Recent Development
 Table 66. Thermo Scientific Chemicals Company Details
 Table 67. Thermo Scientific Chemicals Business Overview
 Table 68. Thermo Scientific Chemicals RNA Modified Pseudouridine Product
 Table 69. Thermo Scientific Chemicals Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 70. Thermo Scientific Chemicals Recent Development
 Table 71. BOC Sciences Company Details
 Table 72. BOC Sciences Business Overview
 Table 73. BOC Sciences RNA Modified Pseudouridine Product
 Table 74. BOC Sciences Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 75. BOC Sciences Recent Development
 Table 76. Toronto Research Chemical Company Details
 Table 77. Toronto Research Chemical Business Overview
 Table 78. Toronto Research Chemical RNA Modified Pseudouridine Product
 Table 79. Toronto Research Chemical Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 80. Toronto Research Chemical Recent Development
 Table 81. Wuhan Glycogene Company Details
 Table 82. Wuhan Glycogene Business Overview
 Table 83. Wuhan Glycogene RNA Modified Pseudouridine Product
 Table 84. Wuhan Glycogene Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 85. Wuhan Glycogene Recent Development
 Table 86. Fine Biotech Company Details
 Table 87. Fine Biotech Business Overview
 Table 88. Fine Biotech RNA Modified Pseudouridine Product
 Table 89. Fine Biotech Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 90. Fine Biotech Recent Development
 Table 91. Shanghai Hongene Biotech Company Details
 Table 92. Shanghai Hongene Biotech Business Overview
 Table 93. Shanghai Hongene Biotech RNA Modified Pseudouridine Product
 Table 94. Shanghai Hongene Biotech Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 95. Shanghai Hongene Biotech Recent Development
 Table 96. Biori Company Details
 Table 97. Biori Business Overview
 Table 98. Biori RNA Modified Pseudouridine Product
 Table 99. Biori Revenue in RNA Modified Pseudouridine Business (2020-2025) & (US$ Million)
 Table 100. Biori Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. RNA Modified Pseudouridine Picture
 Figure 2. Global RNA Modified Pseudouridine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global RNA Modified Pseudouridine Market Share by Type: 2024 VS 2031
 Figure 4. Solution Features
 Figure 5. Powder Features
 Figure 6. Global RNA Modified Pseudouridine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global RNA Modified Pseudouridine Market Share by Application: 2024 VS 2031
 Figure 8. mRNA Vaccines Case Studies
 Figure 9. Gene Expression and Therapy Case Studies
 Figure 10. Other Case Studies
 Figure 11. RNA Modified Pseudouridine Report Years Considered
 Figure 12. Global RNA Modified Pseudouridine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global RNA Modified Pseudouridine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global RNA Modified Pseudouridine Market Share by Region: 2024 VS 2031
 Figure 15. Global RNA Modified Pseudouridine Market Share by Players in 2024
 Figure 16. Global Top RNA Modified Pseudouridine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Modified Pseudouridine as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by RNA Modified Pseudouridine Revenue in 2024
 Figure 18. North America RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America RNA Modified Pseudouridine Market Share by Country (2020-2031)
 Figure 20. United States RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe RNA Modified Pseudouridine Market Share by Country (2020-2031)
 Figure 24. Germany RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific RNA Modified Pseudouridine Market Share by Region (2020-2031)
 Figure 32. China RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America RNA Modified Pseudouridine Market Share by Country (2020-2031)
 Figure 40. Mexico RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa RNA Modified Pseudouridine Market Share by Country (2020-2031)
 Figure 44. Turkey RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE RNA Modified Pseudouridine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. YAMASA CORPORATION Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 48. Biosynth Carbosynth Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 49. TriLink BioTechnologies Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 50. MP Biomedicals, Inc Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 51. Thermo Scientific Chemicals Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 52. BOC Sciences Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 53. Toronto Research Chemical Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 54. Wuhan Glycogene Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 55. Fine Biotech Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 56. Shanghai Hongene Biotech Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 57. Biori Revenue Growth Rate in RNA Modified Pseudouridine Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Pseudouridine Market Research Report 2024
Global Pseudo UTP Market Research Report 2024
Global RNA Modifying Agents Market Research Report 2024
Global Pseudouridine Triphosphate Tetrasodium Salt Solution Market Research Report 2024
Global Modified Nucleosides Market Research Report 2024
Global Methylpseudouridine Triphosphate Solution Market Research Report 2024
Global Guanine Market Research Report 2025
Global DNA Modifying Agents Market Research Report 2024
Global Nucleotide Market Research Report 2024
Global 2 O MOE Phosphoramidites Market Research Report 2024
Global RNA Synthesis Market Research Report 2024
Global N1 Methylpseudouridine Market Research Report 2024
Global RNA Synthesis Kit Market Research Report 2024
Global High Precision Base Editing System Market Research Report 2024
DNA and RNA Modifying Enzyme Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Therapeutics Market Research Report 2024
DNA And RNA Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Stabilizers Market Research Report 2024
Uridine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Deoxyguanosine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions